Sen. Bernie Sanders moves toward another hearing with pharma CEOs
You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…
Category: Medicine
STAT+: Drug shortages and the supply chain are a matter of national security, experts say
WASHINGTON – The pandemic showed how fragile the supply chain can be, and to fix…
Your morning biotech news roundup
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: Vertex and U.K. at odds over value of CF meds; French authorities probe Sanofi over alleged market manipulation
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right…
Opinion: A fertility clinic failure destroyed my chance at motherhood
Kindbody, a fast-growing fertility chain, knowingly exposed countless eggs and embryos to unsafe conditions and…
.jpg)
STAT+: Remote patient monitoring helped manage hypertension better, but at a higher cost
During the pandemic, in search of tools to keep patients healthy and virus-free, doctors turned…
Pulse oximeters’ inaccuracies in darker-skinned people require urgent action, AGs tell FDA
More than two dozen attorneys general are urging Food and Drug Administration officials to take…
Opinion: STAT+: The PATCH Act’s approach to securing medical devices actually gives malicious actors a blueprint
In August 2013, the FDA made news when it issued cybersecurity guidance for medical devices….
Experts talk detecting disease from voice biomarkers with AI, privacy concerns
Over the past few years, researchers have started using AI to capture signals from our…
STAT+: Ventyx stock craters after lackluster mid-stage trial results for psoriasis drug
SAN DIEGO — Ventyx Biosciences reported on Monday that it was ending development of an…
STAT+: Data backing prescription digital therapeutics found lacking in rigor, inclusivity
The fast-evolving world of digital therapeutics offers the promise of lowering barriers to accessing health…
STAT+: Government looks to tinker with new caps on Medicare Advantage broker payments
The federal government is proposing to rein in health insurance companies that entice brokers with…
A new study maps the lasting effects of gun violence on children and teens who survive their injuries
When Christian Pulcini was a pediatric emergency fellow at Children’s Hospital of Philadelphia, he witnessed…
STAT+: HHS secretaries Becerra, Azar face off on lowering drug prices
WASHINGTON — Two very different health secretaries took the stage Monday to defend their presidents’…
STAT+: Moonlake’s credibility takes another hit with mid-stage study spin job
Moonlake Immunotherapeutics, a Swiss biotech, was buried Monday under an avalanche of its own data…
STAT+: Vertex may face another battle in the U.K. over the value of its cystic fibrosis medicines
Once again, Vertex Pharmaceuticals and a U.K. government agency are at odds over the value…
In experiment, electrical stimulation of the spinal cord helps a patient with Parkinson’s to walk
An experimental treatment that delivers an electrical current to the spinal cord appeared to notably…
XBI biotech index rises, giving investors a shred of hope
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: Pharma trade group slams European Commission proposal; U.S. lawmakers demand FDA explain its approach to shortages
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Astellas shows enough data for eye treatment to support expanded use, but still lags competitor
Astellas on Saturday presented study results showing an increased treatment effect over time for its…
Opinion: There’s a real risk that harm reduction could be a fad
Harm reduction is having its moment in America. The doors of drug-related harm reduction have…
As extreme heat soars, laws to protect outdoor workers are bubbling up — and facing resistance
As weather starts to cool in much of the country, the heat-baked cement and sweaty…
STAT turns 8: A letter from the executive editor
Today STAT turns 8. In these annual letters, I usually talk proudly about all we…
STAT+: Medicare moves ahead with more price transparency requirements for hospitals
The federal government is moving forward with a spate of proposals that will force hospitals…
STAT+: Democrats push government to police algorithms in Medicare Advantage
House Democrats are raising concerns with the Biden administration that Medicare Advantage plans need better…
Latest data shows millions of eligible Americans have been disenrolled from Medicaid
More than 10 million people were disenrolled from Medicaid over the past six months, according…
Shrinking COVID vaccine sales has Moderna course-correcting
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: U.S. Senate eyes more policies for regulating PBMs; Novo claims most U.S. Wegovy patients pay less than $25 a month
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Health plan formularies lowered barriers to fair access to some drugs, analysis finds
Most of the formularies run by some of the largest health plans in the U.S….
Opinion: State Prescription Drug Affordability Boards could end up limiting access to the life-saving cystic fibrosis medication Trikafta
I was living on the precipice of end-stage disease when I enrolled in the clinical…
A brain injury turns a writer into an ‘activated patient’ focused on the beauty of the now
How old is Claire Snyman? “I am now…” she says with pause. “I always have…
Opinion: The best way to convince healthy people to get insurance is not ‘because it’s in your financial interest’
’Tis the season — open enrollment season, that is. Since before the Nov. 1 start to…
STAT+: Medicare proceeds with plan to claw back hospital funds after Supreme Court decision
WASHINGTON — Medicare officials are moving forward with a plan to claw back money from certain…
STAT+: Key Senate panel to consider PBM, drug pricing reform package
WASHINGTON — A key Senate panel announced it will consider more policies to regulate pharmacy…
Inari Medical to buy last-line amputation prevention company LimFlow
Vascular device maker Inari Medical announced plans to buy LimFlow, a company selling a last-line…
Rats have an imagination, too, researchers show with brain implants
Our minds have a weird and wondrous way of transporting us to other places and…
Listen: Decoding biotech hype, the Sarepta saga, & au revoir to a CEO
When is a failure not a failure? Does the FDA have special rules for Sarepta…
STAT+: Could kidney transplant patients be spared a lifetime of immunosuppressants?
Kidney transplants are the most common organ transplant procedure in the U.S., with 25,000 taking…
Senate bill would permanently extend Covid-era rules on telehealth addiction treatment
A bipartisan group of senators this week introduced a bill that would permanently allow health…
Novo Nordisk is concluding research on Wegovy’s impact on osteoarthritis
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: Novo Nordisk sees “significantly” more Wegovy in the U.S. next year; U.S. pharma layoffs skyrocket
Top of the morning to you. And a fine one it is. Lots of sunshine…
Opinion: Do celebrity vaccine endorsements like Travis Kelce’s actually change behavior?
Once the domain of aging TV stars, hawking health products from vitamins to diabetes supplies…
Treating Rural America: The telehealth solution
There is a persistent shortage of primary care doctors in the rural United States. Specialists,…
With a new center, All of Us tackles health data silos to power precision medicine
Over the past five years, two unique federal efforts have collected the health records of…
Opinion: Let’s leverage graduate medical education to increase Medicaid re-enrollment
Lately, we’ve seen two distinct lines at our hospitals. We would all be healthier if…
New antibiotic targets gonorrhea as well as last existing treatment, study shows
An important Phase 3 trial has shown that a new drug that targets gonorrhea works…
STAT+: After Sarepta trial failure, families and doctors brace for another debate on Duchenne therapy
To hear Sarepta CEO Doug Ingram tell it, the results Monday afternoon from a large…
STAT+: New insights into how tumor cells hijack brain plasticity to drive cancer
The idea that cancer can hijack brain plasticity — subverting supple connections in the healthy…
STAT+: Nostrum Laboratories and its CEO — who once defended Shkreli price hikes — to pay up to $50 million over Medicaid rebates
A pharmaceutical company and its chief executive — who once defended Martin Shkreli for raising…
American Cancer Society expands lung cancer screening guidelines for cigarette smokers
Most lung cancer screening guidelines hinge on how much people smoked tobacco and when they…